Tower Research Capital LLC (TRC) - C B PHARMA ACQUISITION CORP ownership

C B PHARMA ACQUISITION CORP's ticker is CNLMU and the CUSIP is G2029P100. A total of 6 filers reported holding C B PHARMA ACQUISITION CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of C B PHARMA ACQUISITION CORP
ValueSharesWeighting
Q1 2016$1,0000.0%640.0%0.00%
Q4 2015$1,000
-66.7%
64
-80.0%
0.00%
Q3 2015$3,000320
+742.1%
0.00%
Q2 2015$038
+35.7%
0.00%
Q1 2015$0280.0%0.00%
Q4 2014$0280.00%
Other shareholders
C B PHARMA ACQUISITION CORP shareholders Q1 2015
NameSharesValueWeighting ↓
SENECA CAPITAL INVESTMENTS, L.P. 150,000$1,533,0000.35%
Polar Asset Management Partners Inc. 200,000$2,044,0000.11%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 350,000$3,577,0000.08%
GLAZER CAPITAL, LLC 39,524$404,0000.06%
GOLDMAN SACHS GROUP INC 19,400$198,0000.00%
Tower Research Capital LLC (TRC) 28$00.00%
View complete list of C B PHARMA ACQUISITION CORP shareholders